Skip to content

Perrigo Company PRGO Infant Formula — Net Sales

Other segment segments

Self Care
$543.3M
Specialty Care
$207M

Similar metrics at other companies

Newell Brands logo
NWLBaby — Net Sales
$252M+5.9%
Carter's logo
CRIBaby — Net Sales
$315.15M+10.7%
Kimberly-Clark logo
KMBBaby and Child Care — Net Sales
$1.7B+3.6%
POS
POSTProtein-based products — Net Sales
$38.8M+29.8%
Abbott logo
ABTNutritional Products — Net Sales
$2.02B-6.0%
BellRing Brands logo
BRBRReportable Segment — Net Sales
$598.7M+1.8%

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-62.9%
Enterprise value$4.82B-32.0%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's infant formula — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's infant formula — net sales?
Perrigo Company (PRGO) reported infant formula — net sales of $89.7M in Q1 2026.
What does infant formula — net sales mean?
This metric represents the total revenue generated from the sale of infant formula products within the specified business segment. It reflects the market demand and pricing power of the company's infant nutrition portfolio. Tracking this figure helps investors assess the segment's top-line growth and competitive positioning in the consumer health market.